Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|April 7, 2020
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanomaHsin-Yi Tseng, Jan Dreyer, Abdullah Al Emran, et al.
Molecular Imaging and Biology|June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological HeterogeneityRobert E Ware, Damien Kee, Peter Roselt, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cellsSehrish Kanwal, Natalie Brajanovski, Jiajun Zhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2020
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare CancersOliver Klein, Damien Kee, Ben Markman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibChee Khoon Lee, David Goldstein, Emma Gibbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trialIan D Davis, Ben Brady, Richard F Kefford, et al.
Journal for Immunotherapy of Cancer|November 16, 2021
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trialOliver Klein, Damien Kee, Bo Gao, et al.
JCO Clinical Cancer Informatics|February 22, 2020
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer ResearchDamien Kee, Clare Parker, Susie Bae, et al.
Virchows Archiv : an International Journal of Pathology|August 12, 2019
Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinomaStefan Porubsky, Peter Jessup, Damien Kee, et al.
The Journal of Pathology|December 30, 2014
The genomic landscape of phaeochromocytomaAidan Flynn, Diana Benn, Roderick Clifton-Bligh, et al.
Pageof 10